Dibiraf en es it fr

Dibiraf Brand names, Dibiraf Analogs

Dibiraf Brand Names Mixture

  • No information avaliable

Dibiraf Chemical_Formula

C10H15N5

Dibiraf RX_link

No information avaliable

Dibiraf fda sheet

Dibiraf msds (material safety sheet)

Dibiraf Synthesis Reference

Shapiro, Freedman, U.S. pats. 2,961,377, 3,057,780 (1960, 1962 both to U.S.V.)

Dibiraf Molecular Weight

205.26 g/mol

Dibiraf Melting Point

175-178 oC

Dibiraf H2O Solubility

210 mg/mL

Dibiraf State

Solid

Dibiraf LogP

0.759

Dibiraf Dosage Forms

No information avaliable

Dibiraf Indication

For the reatment of type II diabetes mellitus.

Dibiraf Pharmacology

Used to treat diabetes, phenformin is a biguanide (contains 2 guanidino groups) hypoglycemic agent with actions and uses similar to those of metformin (Glucophage). Both drugs work by (1) decreasing the absorption of glucose by the intestines, (2) decreasing the production of glucose in the liver, and by (3) increasing the body's ability to use insulin more effectively. More specifically, phenformin improves glycemic control by improving insulin sensitivity. Phenformin is generally considered to be associated with an unacceptably high incidence of actic acidosis. In general biguanides should be used only in stable type II diabetics who are free of liver, kidney and cardiovascular problems and who cannot be controlled with diet.

Dibiraf Absorption

No information avaliable

Dibiraf side effects and Toxicity

No information avaliable

Dibiraf Patient Information

No information avaliable

Dibiraf Organisms Affected

Humans and other mammals